Proteomics meets blood banking: Identification of protein targets for the improvement of platelet quality

Journal of Proteomics

Volumn 73, Issue 3, 2010, Pages 436-444

  Schubert, Peter ^a   Devine, Dana V ^a  

^a CANADIAN BLOOD SERVICES   (Canada)

Author keywords

Blood bank storage; In vitro measurements; Platelet; Platelet quality; Proteomics; Transfusion

Indexed keywords

CELL PROTEIN; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; PROTEOME;

BLOOD BANK; DATA ANALYSIS; HUMAN; MOLECULAR DYNAMICS; MONITORING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; QUALITY CONTROL; REVIEW; SIGNAL TRANSDUCTION; THROMBOCYTE; THROMBOCYTE PRESERVATION; THROMBOCYTE TRANSFUSION;

BIOLOGICAL MARKERS; BLOOD BANKS; BLOOD CHEMICAL ANALYSIS; BLOOD PLATELETS; BLOOD PRESERVATION; BLOOD PROTEINS; HUMANS; MODELS, BIOLOGICAL; PROTEOMICS; QUALITY CONTROL;

EID: 72449196658     PISSN: 18743919     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jprot.2009.08.002     Document Type: Review

References (86)

1. Eder A., Goldman M., Rossmann S., Waxman D., and Bianco C. Selection criteria to protect the blood donor in North America and Europe: past (dogma), present (evidence), and future (hemovigilance). Transfus Med Rev 23 (2009) 205-220
2. Seitz R., Heiden M., Nubling C.M., Unger G., and Lower J. The harmonization of the regulation of blood products: a European perspective. Vox Sang 94 (2008) 267-276
3. Patel S.R., Hartwig J.H., and Italiano Jr. J.E. The biogenesis of platelets from megakaryocyte proplatelets. J Clin Invest 115 (2005) 3348-3354
4. Aster R.H. Pooling of platelets in the spleen: role in the pathogenesis of "hypersplenic" thrombocytopenia. J Clin Invest 45 (1966) 645-657
5. Mason K.D., Carpinelli M.R., Fletcher J.I., Collinge J.E., et al. Programmed anuclear cell death delimits platelet life span. Cell 128 (2007) 1173-1186
6. Battinelli E.M., Hartwig J.H., and Italiano Jr. J.E. Delivering new insight into the biology of megakaryopoiesis and thrombopoiesis. Curr Opin Hematol 14 (2007) 419-426
7. Hartwig J., and Italiano Jr. J. The birth of the platelet. J Thromb Haemost 1 (2003) 1580-1586
8. Cutler L., Rodan G., and Feinstein M.B. Cytochemical localization of adenylate cyclase and of calcium ion, magnesium ion-activated ATPases in the dense tubular system of human blood platelets. Biochim Biophys Acta 542 (1978) 357-371
9. White J.G. Interaction of membrane systems in blood platelets. Am J Pathol 66 (1972) 295-312
10. Gnatenko D.V., Perrotta P.L., and Bahou W.F. Proteomic approaches to dissect platelet function: Half the story. Blood 108 (2006) 3983-3991
11. McRedmond J.P., Park S.D., Reilly D.F., Coppinger J.A., et al. Integration of proteomics and genomics in platelets: a profile of platelet proteins and platelet-specific genes. Mol Cell Proteomics 3 (2004) 133-144
12. Booyse F.M., and Rafelson Jr. M.E. Studies on human platelets. I. synthesis of platelet protein in a cell-free system. Biochim Biophys Acta 166 (1968) 689-697
13. Lindemann S., and Gawaz M. The active platelet: translation and protein synthesis in an anucleate cell. Semin Thromb Hemost 33 (2007) 144-150
14. Rosenwald I.B., Pechet L., Han A., Lu L., et al. Expression of translation initiation factors elF-4E and elF-2alpha and a potential physiologic role of continuous protein synthesis in human platelets. Thromb Haemost 85 (2001) 142-151
15. Weyrich A.S., Dixon D.A., Pabla R., Elstad M.R., et al. Signal-dependent translation of a regulatory protein, Bcl-3, in activated human platelets. Proc Natl Acad Sci U S A 95 (1998) 5556-5561
16. Gailani D., and Renne T. Intrinsic pathway of coagulation and arterial thrombosis. Arterioscler Thromb Vasc Biol 27 (2007) 2507-2513
17. Kolev K., and Machovich R. Molecular and cellular modulation of fibrinolysis. Thromb Haemost 89 (2003) 610-621
18. Anitua E., Andia I., Ardanza B., Nurden P., and Nurden A.T. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost 91 (2004) 4-15
19. Sen C.K. The general case for redox control of wound repair. Wound Repair Regen 11 (2003) 431-438
20. Varga-Szabo D., Pleines I., and Nieswandt B. Cell adhesion mechanisms in platelets. Arterioscler Thromb Vasc Biol 28 (2008) 403-412
21. Vassallo R.R., and Murphy S. A critical comparison of platelet preparation methods. Curr Opin Hematol 13 (2006) 323-330
22. Levin E., Culibrk B., Gyongyossy-Issa M.I., Weiss S., et al. Implementation of buffy coat platelet component production: comparison to platelet-rich plasma platelet production. Transfusion 48 (2008) 2331-2337
23. van Delden C.J., de Wit H.J., and Sibinga C.T. Comparison of blood component preparation systems based on buffy coat removal: component specifications, efficiency, and process costs. Transfusion 38 (1998) 860-866
24. Hagberg I.A., Akkok C.A., Lyberg T., and Kjeldsen-Kragh J. Apheresis-induced platelet activation:comparison of three types of cell separators. Transfusion 40 (2000) 182-192
25. Gulliksson H. Defining the optimal storage conditions for the long-term storage of platelets. Transfus Med Rev 17 (2003) 209-215
26. Racz Z., and Thek M. Buffy coat or platelet-rich plasma? Comparison of two platelet-processing techniques. Vox Sang 47 (1984) 108-113
27. Skripchenko A., Kurtz J., Moroff G., and Wagner S.J. Platelet products prepared by different methods of sedimentation undergo platelet activation differently during storage. Transfusion 48 (2008) 1469-1477
28. Heddle N.M., Arnold D.M., Boye D., Webert K.E., et al. Comparing the efficacy and safety of apheresis and whole blood-derived platelet transfusions: a systematic review. Transfusion 48 (2008) 1447-1458
29. de Korte D., Curvers J., de Kort W.L., Hoekstra T., et al. Effects of skin disinfection method, deviation bag, and bacterial screening on clinical safety of platelet transfusions in the Netherlands. Transfusion 46 (2006) 476-485
30. Eder A.F., Kennedy J.M., Dy B.A., Notari E.P., et al. Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience (2004-2006). Transfusion 47 (2007) 1134-1142
31. Castro E., Girones N., Bueno J.L., Carrion J., et al. The efficacy of photochemical treatment with amotosalen HCl and ultraviolet A (INTERCEPT) for inactivation of Trypanosoma cruzi in pooled buffy-coat platelets. Transfusion 47 (2007) 434-441
32. Lozano M., Galan A., Mazzara R., Corash L., and Escolar G. Leukoreduced buffy coat-derived platelet concentrates photochemically treated with amotosalen HCl and ultraviolet A light stored up to 7 days: assessment of hemostatic function under flow conditions. Transfusion 47 (2007) 666-671
33. Sawyer L., Hanson D., Castro G., Luckett W., et al. Inactivation of parvovirus B19 in human platelet concentrates by treatment with amotosalen and ultraviolet A illumination. Transfusion 47 (2007) 1062-1070
34. Cardigan R., and Williamson L.M. The quality of platelets after storage for 7 days. Transfus Med 13 (2003) 173-187
35. Kunicki T.J., Tuccelli M., Becker G.A., and Aster R.H. A study of variables affecting the quality of platelets stored at "room temperature". Transfusion 15 (1975) 414-421
36. Milton J.G., and Frojmovic M.M. Adrenaline and adenosine diphosphate-induced platelet aggregation require shape change. Importance of pseudopods. J Lab Clin Med 104 (1984) 805-815
37. Kim B.K., and Baldini M.G. The platelet response to hypotonic shock. Its value as an indicator of platelet viability after storage. Transfusion 14 (1974) 130-138
38. Slichter S.J. Poststorage platelet viability in thrombocytopenic recipients is reliably measured by radiochromium-labeled platelet recovery and survival measurements in normal volunteers. Transfusion 26 (1986) 8-13
39. Liumbruno G., D'Amici G.M., Grazzini G., and Zolla L. Transfusion medicine in the era of proteomics. J Proteomics 71 (2008) 34-45
40. Thadikkaran L., Siegenthaler M.A., Crettaz D., Queloz P.A., et al. Recent advances in blood-related proteomics. Proteomics 5 (2005) 3019-3034
41. Issaq H.J., Xiao Z., and Veenstra T.D. Serum and plasma proteomics. Chem Rev 107 (2007) 3601-3620
42. Pasini E.M., Kirkegaard M., Mortensen P., Lutz H.U., et al. In-depth analysis of the membrane and cytosolic proteome of red blood cells. Blood 108 (2006) 791-801
43. Garcia A., Prabhakar S., Brock C.J., Pearce A.C., et al. Extensive analysis of the human platelet proteome by two-dimensional gel electrophoresis and mass spectrometry. Proteomics 4 (2004) 656-668
44. Maguire P.B., and Fitzgerald D.J. Platelet proteomics. J Thromb Haemost 1 (2003) 1593-1601
45. Marcus K., Immler D., Sternberger J., and Meyer H.E. Identification of platelet proteins separated by two-dimensional gel electrophoresis and analyzed by matrix assisted laser desorption/ionization-time of flight-mass spectrometry and detection of tyrosine-phosphorylated proteins. Electrophoresis 21 (2000) 2622-2636
46. Martens L., Van Damme P., Van Damme J., Staes A., et al. The human platelet proteome mapped by peptide-centric proteomics: a functional protein profile. Proteomics 5 (2005) 3193-3204
47. O'Neill E.E., Brock C.J., von Kriegsheim A.F., Pearce A.C., et al. Towards complete analysis of the platelet proteome. Proteomics 2 (2002) 288-305
48. Perrotta P.L., and Bahou W.F. Proteomics in platelet science. Curr Hematol Rep 3 (2004) 462-469
49. Garcia A., Prabhakar S., Hughan S., Anderson T.W., et al. Differential proteome analysis of TRAP-activated platelets: involvement of DOK-2 and phosphorylation of RGS proteins. Blood 103 (2004) 2088-2095
50. Garcia A., Senis Y.A., Antrobus R., Hughes C.E., et al. A global proteomics approach identifies novel phosphorylated signaling proteins in GPVI-activated platelets: involvement of G6f, a novel platelet Grb2-binding membrane adapter. Proteomics 6 (2006) 5332-5343
51. Moebius J., Zahedi R.P., Lewandrowski U., Berger C., et al. The human platelet membrane proteome reveals several new potential membrane proteins. Mol Cell Proteomics 4 (2005) 1754-1761
52. Garcia B.A., Smalley D.M., Cho H., Shabanowitz J., et al. The platelet microparticle proteome. J Proteome Res 4 (2005) 1516-1521
53. Maynard D.M., Heijnen H.F., Horne M.K., White J.G., and Gahl W.A. Proteomic analysis of platelet alpha-granules using mass spectrometry. J Thromb Haemost 5 (2007) 1945-1955
54. Hernandez-Ruiz L., Valverde F., Jimenez-Nunez M.D., Ocana E., et al. Organellar proteomics of human platelet dense granules reveals that 14-3-3zeta is a granule protein related to atherosclerosis. J Proteome Res 6 (2007) 4449-4457
55. Zahedi R.P., Begonja A.J., Gambaryan S., and Sickmann A. Phosphoproteomics of human platelets: A quest for novel activation pathways. Biochim Biophys Acta 1764 (2006) 1963-1976
56. Lewandrowski U., Zahedi R.P., Moebius J., Walter U., and Sickmann A. Enhanced N-glycosylation site analysis of sialoglycopeptides by strong cation exchange prefractionation applied to platelet plasma membranes. Mol Cell Proteomics 6 (2007) 1933-1941
57. Snyder E.L., Dunn B.E., Giometti C.S., Napychank P.A., et al. Protein changes occurring during storage of platelet concentrates. A two-dimensional gel electrophoretic analysis. Transfusion 27 (1987) 335-341
58. Garcia A. Proteome analysis of signaling cascades in human platelets. Blood Cells Mol Dis 36 (2006) 152-156
59. Ong S.E., and Mann M. Mass spectrometry-based proteomics turns quantitative. Nat Chem Biol 1 (2005) 252-262
60. Thiele T., Steil L., Gebhard S., Scharf C., et al. Profiling of alterations in platelet proteins during storage of platelet concentrates. Transfusion 47 (2007) 1221-1233
61. Li J., Xia Y., Bertino A.M., Coburn J.P., and Kuter D.J. The mechanism of apoptosis in human platelets during storage. Transfusion 40 (2000) 1320-1329
62. Seghatchian J., and Krailadsiri P. Platelet storage lesion and apoptosis: are they related?. Transfus Apher Sci 24 (2001) 103-105
63. Thon J.N., Schubert P., Duguay M., Serrano K., et al. Comprehensive proteomic analysis of protein changes during platelet storage requires complementary proteomic approaches. Transfusion 48 (2008) 425-435
64. Glenister K.M., Payne K.A., and Sparrow R.L. Proteomic analysis of supernatant from pooled buffy-coat platelet concentrates throughout 7-day storage. Transfusion 48 (2008) 99-107
65. Greening D.W., Glenister K.M., Kapp E.A., Moritz R.L., et al. Comparison of human platelet membrane-cytoskeletal proteins with the plasma proteome: towards understanding the platelet-plasma nexus. Proteomics Clin Appl 2 (2008) 63-77
66. Coppinger J.A., Cagney G., Toomey S., Kislinger T., et al. Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Blood 103 (2004) 2096-2104
67. Stratmann B., and Tschoepe D. Pathobiology and cell interactions of platelets in diabetes. Diab Vasc Dis Res 2 (2005) 16-23
68. Springer D.L., Miller J.H., Spinelli S.L., Pasa-Tolic L., et al. Platelet proteome changes associated with diabetes and during platelet storage for transfusion. J Proteome Res 8 (2009) 2261-2272
69. Zhang Y., Adachi J., Olsen J.V., Shi R., et al. MAPU: Max-Planck unified database of organellar, cellular, tissue and body fluid proteomes. Nucleic Acids Res 35 (2007) D771-D779
70. Dittrich M., Birschmann I., Mietner S., Sickmann A., et al. Platelet protein interactions: map, signaling components, and phosphorylation groundstate. Arterioscler Thromb Vasc Biol 28 (2008) 1326-1331
71. Cagney G., and McRedmond J. A central resource for platelet proteomics. Arterioscler Thromb Vasc Biol 28 (2008) 1214-1215
72. Aebersold R., and Mann M. Mass spectrometry-based proteomics. Nature 422 (2003) 198-207
73. Schubert P, Thon JN, Walsh GM, Chen CH, et al. A signaling pathway contributing to platelet storage lesion development: Targeting PI3-kinase-dependent Rap1 activation slows storage-induced platelet deterioration. Transfusion 2009;49(9):1944-55.
74. Weyrich A.S., Schwertz H., Kraiss L.W., and Zimmerman G.A. Protein synthesis by platelets: historical and new perspectives. J Thromb Haemost 7 (2009) 241-246
75. Thon J.N., and Devine D.V. Translation of glycoprotein IIIa in stored blood platelets. Transfusion 47 (2007) 2260-2270
76. Kieffer N., Guichard J., Farcet J.P., Vainchenker W., and Breton-Gorius J. Biosynthesis of major platelet proteins in human blood platelets. Eur J Biochem 164 (1987) 189-195
77. Schubert P., Coupland D., Walsh G.M., Chen C.H., and Devine D.V. From Venus and Mars: Gender Specific Analysis of Blood Platelet. Blood (2008), American Society of Hematology, San Francisco, USA abstract #993
78. Schubert P., and Devine D.V. The application of proteomics to blood banking. Vox sanguinis 3 (2008) 30-36 ISBT science series
79. Dittrich M., Birschmann I., Stuhlfelder C., Sickmann A., et al. Understanding platelets. Lessons from proteomics, genomics and promises from network analysis. Thromb Haemost 94 (2005) 916-925
80. Nita-Lazar A., Saito-Benz H., and White F.M. Quantitative phosphoproteomics by mass spectrometry: past, present, and future. Proteomics 8 (2008) 4433-4443
81. Broillet M.C. S-nitrosylation of proteins. Cell Mol Life Sci 55 (1999) 1036-1042
82. Schlossmann J., Feil R., and Hofmann F. Signaling through NO and cGMP-dependent protein kinases. Ann Med 35 (2003) 21-27
83. Bermejo E., Saenz D.A., Alberto F., Rosenstein R.E., et al. Effect of nitroxyl on human platelets function. Thromb Haemost 94 (2005) 578-584
84. Hoffman M.D., Walsh G.M., Rogalski J.C., and Kast J. Identification of nitroxyl-induced modifications in human platelet proteins using a novel mass spectrometric detection method. Mol Cell Proteomics 8 (2009) 887-903
85. Thiele T., Steil L., Volker U., and Greinacher A. Proteomics of blood-based therapeutics: a promising tool for quality assurance in transfusion medicine. BioDrugs 21 (2007) 179-193
86. Zhang J.G., Carter C.J., Devine D.V., Scammell K., et al. Comparison of a novel viscous platelet additive solution and plasma: preparation and in vitro storage parameters of buffy-coat-derived platelet concentrates. Vox Sang 94 (2008) 299-305